KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Income from Continuing Operations (2016 - 2025)

Resmed (RMD) has disclosed Income from Continuing Operations for 17 consecutive years, with 392594000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 13.92% year-over-year to 392594000.0, compared with a TTM value of 1485877000.0 through Dec 2025, up 18.99%, and an annual FY2025 reading of 1400723000.0, up 37.2% over the prior year.
  • Income from Continuing Operations was 392594000.0 for Q4 2025 at Resmed, up from 348536000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 392594000.0 in Q4 2025 and bottomed at 179012000.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 262645150.0, with a median of 227289000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations dropped 17.89% in 2022, then skyrocketed 65.05% in 2024.
  • Year by year, Income from Continuing Operations stood at 201751000.0 in 2021, then increased by 11.48% to 224914000.0 in 2022, then fell by 7.16% to 208800000.0 in 2023, then surged by 65.05% to 344621000.0 in 2024, then grew by 13.92% to 392594000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for RMD at 392594000.0 in Q4 2025, 348536000.0 in Q3 2025, and 379706000.0 in Q2 2025.